Orange Book product · Brand (NDA)
OLINVYK
OLICERIDINE
At a glance
Oct 30, 2020
Approved
Brand (NDA)
Application
Not listed
TE code
5
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 30, 2020
5 yr 9 mo ago
Today
Patent 11077098 expires
Listed drug substance patent expiration.
Mar 23, 2032
in 5 yr 10 mo
Patent 11931350 expires
Listed drug substance patent expiration.
Mar 23, 2032
in 5 yr 10 mo
Patent 8835488 expires
Listed drug substance patent expiration.
Mar 23, 2032
in 5 yr 10 mo
Patent 9309234 expires
Listed drug substance patent expiration.
Mar 23, 2032
in 5 yr 10 mo
Patent 9642842 expires
Listed drug product patent expiration.
Mar 23, 2032
in 5 yr 10 mo
Pharmaceutical detail
Active ingredient
OLICERIDINE
Strength
1MG/ML (1MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 210730
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (5)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11077098 | Mar 23, 2032 | in 5 yr 10 mo | SubstanceProductU-2986 |
| 11931350 | Mar 23, 2032 | in 5 yr 10 mo | SubstanceU-2986 |
| 8835488 | Mar 23, 2032 | in 5 yr 10 mo | SubstanceProductU-2986 |
| 9309234 | Mar 23, 2032 | in 5 yr 10 mo | SubstanceProductU-2986 |
| 9642842 | Mar 23, 2032 | in 5 yr 10 mo | ProductU-2986 |
